Other functions include the downregulation of the glycolytic pathway to impose an anti-Warburg impact [13,14], halt the cell cycle in conjunction with the stabilisation of p53 and p27Kip1 [15], and combat the epithelial–mesenchymal transition related to tumor invasion and metastasis [16]. This evidence concerns the gene TP53 and neoplasm.